AlzhiNet

An Explainable Self-Attention Based Classification Model to Detect Alzheimer’s from 3D Volumetric MRI Data.

Current emphasis on targeting glutaminase for cancer therapy. Glutaminase (GLS) is a pivotal enzyme responsible for breaking down glutamine within cancer cells. Glutamine addiction, characterized by the heightened dependence of cancer cells on glutamine for their metabolic needs, is a hallmark of cancer metabolism. Deprivation of glutamine deprives cancer cells of a crucial energy source, ultimately leading to their demise.

By harnessing advanced AI algorithms, our product sifts through vast datasets and complex molecular interactions to identify promising candidates for targeting glutaminase as a therapeutic strategy

This approach allows for the rapid screening and prioritization of potential drug candidates, significantly expediting the drug discovery process.